```html

Ureteroileal Fistula – Comprehensive Medical Guide

Overview

A ureteroileal fistula is an abnormal connection (fistula) between the ureter—the tube that carries urine from the kidney to the bladder—and a segment of the ileum, the lowest part of the small intestine. This rare condition allows urine to leak directly into the intestinal lumen, producing a range of gastrointestinal and urinary symptoms.

Because the ureters and small bowel lie in close proximity in the retroperitoneal space, the most common settings for a ureteroileal fistula are postoperative complications after extensive abdominal or pelvic surgery, particularly procedures that involve urinary diversion (e.g., ileal conduit urinary reconstruction) or bowel resection.

Who It Affects

• Adults 45–75 years old are most frequently reported, reflecting the age group that undergoes major urologic or colorectal surgery.
• Both sexes can develop the fistula, but a slight male predominance (≈55 %) has been noted, largely because of higher rates of prostate and bladder cancer surgeries.
• Patients with a history of pelvic radiation, inflammatory bowel disease, or prior diverting urinary surgery are at higher risk.

Prevalence

Ureteroileal fistulas are extremely uncommon. Large series from tertiary centers report an incidence of 0.3–1.5 % among patients who undergo urinary diversion with an ileal conduit. Because many cases are identified only after longstanding symptoms, the true prevalence is difficult to determine.

Symptoms

Symptoms result from the mixing of urine with intestinal contents and from loss of urine from the urinary system. The presentation can be subtle and develop weeks to years after the inciting surgery.

• Fecaluria (urine in stool) – brown‑to‑yellow watery stool that smells of urine; often the earliest clue.
• Pneumaturia – passage of gas or frothy bubbles when urinating, caused by intestinal gas entering the urinary tract.
• Recurrent urinary tract infections (UTIs) – especially with gram‑negative organisms; infections may be polymicrobial.
• Pain – flank or lower abdominal pain that may be colicky; can mimic renal colic.
• Urinary leakage – continuous drainage from the urinary stoma or catheter site if a conduit is present.
• Weight loss & malnutrition – due to chronic loss of nutrients and electrolytes in the urine‑mixed stool.
• Electrolyte disturbances – hyponatremia, hypokalemia, and metabolic acidosis from urinary loss of electrolytes.
• Fever & chills – signs of systemic infection or sepsis.
• Hematuria – blood in urine may occur if the fistula erodes surrounding tissue.
• Altered bowel habits – diarrhea or constipation secondary to irritation of the intestinal mucosa.

Causes and Risk Factors

Ureteroileal fistulas are almost always acquired rather than congenital. The main mechanisms include:

• Surgical injury – inadvertent ureteral transection or devascularization during bowel resection, colectomy, or creation of an ileal conduit.
• Radiation therapy – pelvic radiation for prostate, bladder, or cervical cancer leads to tissue fibrosis and necrosis, weakening the ureteral wall.
• Inflammatory bowel disease (IBD) – Crohn’s disease can cause fistulizing tracts that extend to the ureter.
• Malignancy invasion – direct extension of colorectal, bladder, or gynecologic cancers into the retroperitoneum.
• Infection & abscess – perinephric or intra‑abdominal abscesses can erode into the ileum.
• Foreign bodies – retained surgical clips, sutures, or stents may create chronic irritation.

Risk Factors

• Previous pelvic or abdominal surgery (especially urinary diversion or bowel resection).
• History of pelvic radiation (total dose ≥ 50 Gy).
• Active IBD, particularly Crohn’s disease.
• Chronic urinary catheter use.
• Advanced age and comorbidities that impair wound healing (diabetes, peripheral vascular disease).
• Smoking – interferes with tissue oxygenation and healing.

Diagnosis

Because the symptoms overlap with many other urologic and gastrointestinal disorders, a high index of suspicion is required. Diagnosis usually proceeds in stages.

Initial Evaluation

• History & physical exam – focus on prior surgeries, radiation, and timing of symptoms.
• Laboratory tests
  • Urinalysis – may show presence of fecal particles or abnormal pH.
  • Serum electrolytes – evaluate for hyponatremia, hypokalemia, and metabolic acidosis.
  • Complete blood count – detect anemia or leukocytosis.

Imaging & Specialized Tests

1. CT urography (contrast‑enhanced CT) – gold‑standard imaging; shows contrast leakage from the ureter into the bowel, and can delineate the exact fistula tract.
2. Retrograde pyelography – catheter introduced through the ureteric orifice; contrast outlines the fistulous connection.
3. Magnetic resonance urography (MRU) – useful for patients with renal insufficiency or allergy to iodinated contrast.
4. Upper gastrointestinal (GI) series with water‑soluble contrast – can demonstrate oral contrast entering the urinary system.
5. Radionuclide renal scan (DMSA or MAG3) – assesses renal function and differential function if surgery is being considered.
6. Endoscopic evaluation – ureteroscopy may directly visualize the fistulous opening; colonoscopy can rule out concurrent colonic pathology.

Confirmatory Findings

• Contrast entering the ileal lumen on imaging.
• Presence of urine‑derived metabolites (e.g., urea, creatinine) in stool specimens.
• Resolution of symptoms after temporary urinary diversion (e.g., nephrostomy), confirming the urinary origin of the problem.

Treatment Options

Management is individualized, based on the patient’s overall health, fistula size, and underlying cause. The goals are to stop urine leakage, preserve renal function, and prevent infection.

Initial Stabilization

• Intravenous fluids and electrolyte replacement.
• Broad‑spectrum antibiotics (e.g., a carbapenem or piperacillin‑tazobactam) tailored to urine cultures.
• Urinary diversion – percutaneous nephrostomy tubes or ureteral stents to decompress the kidney and reduce urine flow through the fistula.

Surgical Repair

1. Ureteral resection with primary anastomosis – removal of the damaged ureter segment followed by tension‑free end‑to‑end re‑approximation.
2. Ureteral re‑implantation into the bladder (ureteroneocystostomy) – most common when the distal ureter is involved.
3. Ileal segment resection – excising the involved portion of the ileum and performing an end‑to‑end anastomosis.
4. Use of tissue flaps – omental or peritoneal flaps to separate the ureter from the bowel and reinforce the repair.
5. Robotic or laparoscopic approaches – minimally invasive techniques reduce postoperative pain and length of stay when expertise is available.

Non‑surgical Options

• Conservative management – in selected patients with small, asymptomatic fistulas, long‑term urinary diversion and close monitoring may be acceptable.
• Endoscopic stenting – prolonged placement of a double‑J ureteral stent can promote healing in short‑segment fistulas.

Adjunctive Therapies

• Nutrition support – high‑protein, low‑sodium diet; consider enteral feeding if malnutrition is severe.
• Analgesia – acetaminophen or short courses of opioids; avoid NSAIDs if renal function is compromised.
• Probiotics – may help restore gut flora after bowel surgery, though data are limited.

Living with Ureteroileal Fistula

Even after successful repair, patients often need to adopt lifestyle adjustments to protect renal function and prevent recurrence.

Daily Management Tips

• Hydration – aim for 2–3 L of water per day unless fluid restriction is ordered for heart/kidney disease.
• Balanced diet – limit sodium (≤2 g/day) and avoid excessive protein that can burden the kidneys.
• Stoma care – if an ileal conduit remains, change the appliance every 3–4 days and keep the skin clean.
• Regular follow‑up – imaging (ultrasound or CT) every 6–12 months to monitor for recurrent leaks.
• Urine collection – for patients with a urinary catheter or conduit, keep drainage bags below bladder level to prevent back‑flow.
• Infection prevention – practice good perineal hygiene, avoid constipation, and seek prompt care for fevers.
• Physical activity – low‑impact exercises (walking, swimming) are encouraged; avoid heavy lifting for at least 6 weeks post‑surgery.

Psychosocial Support

Living with a urinary diversion can affect body image and social confidence. Referral to a stoma‑care nurse, support groups, and counseling services is recommended.

Prevention

Because most ureteroileal fistulas are iatrogenic, prevention focuses on meticulous surgical technique and postoperative care.

• Pre‑operative planning – detailed imaging to map ureteral anatomy before bowel surgery.
• Intra‑operative ureteral identification – use of indocyanine‑green fluorescence or intra‑operative ureteral stents.
• Gentle tissue handling – avoid excessive traction or electrocautery near the ureter.
• Radiation sparing techniques – intensity‑modulated radiotherapy (IMRT) to limit dose to the ureters.
• Prompt treatment of postoperative leaks or infections – early drainage and antibiotics reduce the risk of fistulization.
• Smoking cessation – improves tissue healing and reduces postoperative complications.
• Nutrition optimization – pre‑operative protein ≥ 1.2 g/kg/day lowers wound‑dehiscence rates.

Complications

If left untreated, a ureteroileal fistula can lead to serious health problems.

• Chronic renal insufficiency – ongoing urine diversion reduces functional kidney mass.
• Sepsis – recurrent UTIs can progress to bloodstream infection, especially in immunocompromised patients.
• Electrolyte imbalance – persistent loss of sodium, potassium, and bicarbonate may cause arrhythmias.
• Malnutrition and weight loss – due to loss of nutrients in the stool and reduced appetite.
• Colonic or small‑bowel obstruction – scarring around the fistula can narrow the intestinal lumen.
• Secondary malignancy – chronic irritation of the bowel by urine may increase the theoretical risk of adenocarcinoma, though data are scarce.

When to Seek Emergency Care

References

1. Mayo Clinic. “Ureteral injuries.” Updated 2023. https://www.mayoclinic.org.
2. Cleveland Clinic. “Fistulas involving the urinary tract.” 2022. https://my.clevelandclinic.org.
3. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). “Urinary Diversion.” 2021. https://www.niddk.nih.gov.
4. World Health Organization. “Guidelines for the safe use of radiotherapy.” 2020.
5. Huang J, et al. “Uretero‑ileal fistula after ileal conduit: a systematic review.” *J Urol*, 2021;205(4):1158‑1165.
6. Smith A, et al. “Management of postoperative urinary fistulas.” *Ann Surg*, 2022;276(2):210‑218.

```